36 related articles for article (PubMed ID: 9744011)
1. [Normal levels of collagen-type-I telopeptide in the first 90 days of life].
Praticò G; Caltabiano L; Palano GM; Zingale A
Pediatr Med Chir; 1998; 20(3):193-5. PubMed ID: 9744011
[TBL] [Abstract][Full Text] [Related]
2. [Normal urinary levels of telopeptide aminoterminal (NTx) of type I collagen in healthy term newborns and infants in the first month of life].
Praticò G; Palano GM; Curreri R; D'Agata A; Carpinato C; Sottile F; Sorge A
Pediatr Med Chir; 2002; 24(3):213-6. PubMed ID: 12236035
[TBL] [Abstract][Full Text] [Related]
3. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
4. [Normal levels of carboxyterminal propeptide of type I procollagen in the first three months of life].
Praticò G; Caltabiano L; Palano GM; Sciacca P; D'Agata A
Pediatr Med Chir; 1995; 17(2):127-9. PubMed ID: 7610074
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
[TBL] [Abstract][Full Text] [Related]
6. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Noguchi M; Noda S
J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
8. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
[TBL] [Abstract][Full Text] [Related]
14. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression.
Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; Möttönen T;
Scand J Rheumatol; 2008; 37(2):90-3. PubMed ID: 18415764
[TBL] [Abstract][Full Text] [Related]
15. Comparison of carboxyterminal telopeptide of type I collagen (ICTP) and CA 125 as predictors of prognosis in ovarian cancer.
Santala M; Risteli J; Kauppila A
Anticancer Res; 2004; 24(2C):1057-62. PubMed ID: 15154623
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
[TBL] [Abstract][Full Text] [Related]
17. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
[TBL] [Abstract][Full Text] [Related]
18. Concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum of young growing rats fed a low calcium and vitamin D-deficient diet.
Bielaczyc AR; Gołebiewska M; Citko A; Rogowski F
Eur J Clin Chem Clin Biochem; 1997 Dec; 35(12):915-8. PubMed ID: 9476619
[TBL] [Abstract][Full Text] [Related]
19. [ICTP].
Yamamoto I
Nihon Rinsho; 1999 Sep; 57 Suppl():211-4. PubMed ID: 10543089
[No Abstract] [Full Text] [Related]
20. Biological variation in serum type I collagen carboxy-terminal telopeptide concentrations.
Pagani F; Panteghini M
Clin Chem; 2000 Sep; 46(9):1439-40. PubMed ID: 10973884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
